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Handled by Zhao-Qi WangResearch concerning senescence has become a hotspot since
the conception of ‘cellular senescence’ was put forward by
Drs. Hayflick and Moorhead over five decades ago [1].
Recently, a paper published in Science by Kang and
colleagues, which this article aims to comment on, provides
evidence of a new pathway involved in senescence [2].
Senescence is a physiological and pathological process
induced by numerous factors, during which cell growth ceases
and gene expression alters. As can be imagined, such state
protects against the development of cancer and plays an
important role in tissue repair [3]. On the other hand,
senescence is involved in many other processes such as aging
and neurodegenerative disease [4–6]. Recent studies show that
senescent cells produce senescence-associated secretory
phenotype (SASP) factors including chemokines, proteases,
pro-inflammatory cytokines, growth factors, macrophage
inflammatory proteins (MIPs), and granulocyte–macrophage
colony-stimulating factors (GM-CSFs) [7,8]. It is known that
SASP is mediated by the transcription factors NF-jB [9]. But
how SASP is initiated and maintained is not clear.
There are up to 106 DNA damages happening in each cell
per day. To respond to these threats, cells evolve the DNA
damage response (DDR) system to sense and repair the dam-
ages if these damages are not so severe. However, if the dam-
ages are beyond the capability of the cell to repair, DDR willdirect other ways to maintain the genomic stability, such as
apoptosis and senescence [10]. In other words, upon the stimuli
such as ionizing radiation, genotoxic drugs, or replication
errors, cells may undergo senescence [11].
GATA4, a GATA family member, is a transcriptional
regulator, which possesses a zinc-finger domain. GATA4 is
well recognized for its involvement in the regulation of
embryonic development of heart, testis, ovary, ventral
pancreas [12,13]. In the work by Kang et al. it is shown for
the first time that GATA4 plays a critical role in mediating
senescence [2].
Traditionally it is thought that DDR induces cellular
senescence primarily through two pathways. One pathway
requires the mediation by p53. When receiving a signal from
DDR, p53 is activated and induces the expression of p21, a
cyclin-dependent kinase (CDK) inhibitor, arresting the progress
of the cell cycle [14,15]. The other is p16-retinoblastoma (pRB)
pathway, which works by inducing the expression of p16,
another CDK inhibitor. p16 keeps pRB in an active state
and blocks cell proliferation by suppressing E2F, a transcrip-
tion factor regulating cell cycle, thus leading to growth arrest
[15]. Both pathways ultimately act on cell cycle and achieve
growth arrest [16].
In their paper, Kang et al. establish a new DDR-inducing
senescence pathway, in which GATA4 mediates cellular senes-
cence, not by inhibiting cell cycle but by regulating SASP
through NF-jB. In this pathway, GATA4 is regulated by
autophagy, rather than, generally thought, by protease [2].
The experiments were well organized and elaborately designed.
The authors demonstrate GATA4 as a novel senescence regu-
lator by evaluating the influence of ectopic expression of
GATA4 in normal cells. Since proteins are degraded by eithernces and
Figure 1 Pathways of DDR-induced senescence
Upon the signal from DDR, the two upstream kinases, ATM and ATR, are activated, initiating the senescence. Classical senescence routes
consist of the p53 pathway and p16-pRB pathway, which act on arresting cell cycle. The third one is mediated by GATA4, which functions
by regulating SASP, finally resulting in senescence. DDR, DNA damage response; ATM, ataxia telangiectasia mutated; ATR, ataxia
telangiectasia and Rad3-related; pRB, retinoblastoma; SASP, senescence-associated secretory phenotype; PRC2, polycomb repressive
complex 2; MDM2, mouse double minute 2 homolog.
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pathway in eukaryotic cells, the cells were treated with inhibi-
tors of these two pathways, respectively. As a result, GATA4
was found to be regulated through the autophagy pathway.
Then, the authors designed a set of experiments to figure out
the upstream regulators and downstream effectors of GATA4
and finally established a new branch of senescence regulatory
pathway [2]. In this GATA4 pathway, DDR is the initiator
of senescence process, which activates the two key kinases,
ataxia telangiectasia mutated (ATM) and ataxia telangiectasia
and Rad3-related (ATR) [17]. Both ATM and ATR inhibit
p62, an autophagy adaptor responsible for selective autophagy
of GATA4, resulting in the increase of GATA4. NF-jB is then
activated through tumor necrosis factor receptor-associated
factor interacting protein 2 (TRAF3IP2) and interleukin 1A
(IL1A), finally inducing the secretion of SASP factors and
leading to senescence [2] (Figure 1).
The authors went further and put forward an idea to patch
up the historic argument concerning whether autophagy has
positive or negative effect on senescence [18]. Some previous
studies suggest that autophagy is important for the establish-
ment of senescence, while others are indicative of the protec-
tion effect of autophagy against senescence [19,20]. In the
present work, autophagy is divided into two types, selective
autophagy and general autophagy. While selective autophagy
decreases the expression of senescence-positive factors such
as GATA4, general autophagy results in senescence. When
given senescence-inducing stimuli, selective autophagy is firstly
initiated, protecting cells against senescence. Subsequently,
general autophagy starts, leading to cellular senescence [2].
It’s obvious that this study is of great importance both in
scientific research and in clinical practice. For example, from
now on, GATA4 will be considered not only a transcription
factor involved in embryonic development, but also an essen-
tial component in senescence regulation. Also, it’s not hard
to imagine that a new model for senescence aiming at GATA4
pathway could be established in the near future. As for clinical
trials, novel targets for drug design and development are going
to emerge, indicative of new therapeutic methods. No doubt,
this work could provide insight into the intervention and treat-
ment of cancer, premature senescence, neurodegeneration and
aging-related diseases.
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